1. Axelsson, R.: Clinical pharmacokinetics of a neuroleptic drug. A study of patients treated with thioridazine and thioridazine metabolites. Psychiatric Department III, University of Göteborg, Lillhagens Hospital, Göteborg. Göteborg 1977
2. Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395?405 (1973)
3. Fann, W. E., Stafford, L. R., Wheless, J.: Tardive dyskinesia and antipsychotics. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 457?468. Oxford, New York: Pergamon 1977
4. Faurbye, A.: The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal disease. Compr. Psychiatry 11, 205?225 (1970)
5. Friedhoff, A. J.: The psychiatric clinical syndrome and essential corresponding qualities of an animal model of receptor sensitivity modification. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 51?59. Oxford, New York: Pergamon 1977